Actions

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Bearish
3
Neutral
1
Bullish
10
Bearish
35
Neutral
1
Bullish
10
Bearish
32
Neutral
0
Bullish
0
Bearish
3
Neutral
1
Bullish
10
Bearish
3
Neutral
1
Bullish
10
Bearish
32
Neutral
0
Bullish
0
Bearish
32
Neutral
0
Bullish
0
Bearish
32
Neutral
0
Bullish
0
Investor Presentation
Q4 FY26
Investor Presentation
Q3 FY26
Investor Presentation
Q2 FY26
Investor Presentation
Q1 FY26
Investor Presentation
Q4 FY25
Investor Presentation
Q3 FY25
Investor Presentation
Q2 FY25
Insurance
General Insurance
13,509 Cr
Low Risk
77.7
14.3
-1.8
3.6
91.20
67.50
Sales CAGR
Profit CAGR
ROE
ROCE

Niva Bupa Health Insurance Company Ltd (NIVABUPA) is currently trading at 72.50 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Niva Bupa Health Insurance Company Limited is a standalone health insurer focusing on the retail health market. It underwrites health insurance, personal accident, critical illness, and travel insurance products in India. The company is a joint venture between Bupa Singapore Holdings and Fettle Tone LLP. In 9M'FY2026, Niva Bupa reported a Gross Written Premium (GWP) of ₹6,309 crore, up 25.9% year-on-year. Profit after tax for the same period stood at ₹208 crore, reflecting a robust growth of 74.3% over the previous year. Niva Bupa's digital transformation and multi-channel distribution approach have significantly expanded business reach, with digital channels showing an impressive growth of 49% for the nine months. Their Retail Health market share increased to 10.0%. The introduction of Niva Bupa's ReAssure 3.0 product, designed to combat high medical inflation, has been successful since its launch. It offers unlimited sum insured and comprehensive OPD services, enhancing customer attraction and retention. The company maintains a strong focus on technological advancements, evidenced by its AI-driven claims management and customer engagement processes. These initiatives aim to enhance efficiency and customer satisfaction.
Over the past 52 weeks, Niva Bupa Health Insurance Company Ltd has traded between a low of ₹67.50 and a high of ₹91.20. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Niva Bupa Health Insurance Company Ltd has a market capitalization of approximately 13,508.65. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Niva Bupa Health Insurance Company Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 77.71 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 13,508.65 Cr, Niva Bupa Health Insurance Company Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Niva Bupa Health Insurance Company Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Niva Bupa Health Insurance Company Ltd is 77.71. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Niva Bupa reported net profit of Rs 138 crore in Q1 FY27, according to an exchange filing.
The board meeting to consider Niva Bupa’s Q1 FY27 financial results is scheduled for July 30, 2026.
The IPO issue (allotment) price was ₹74 per share, within a price band of ₹70-74.
Net earned premium grew 28% to INR 4,894 crore in FY25.